tiprankstipranks
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market
APLLTD
Alembic Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see IN:APLLTD full AI Analyst Report?

Alembic Pharmaceuticals Limited (APLLTD) Income Statement

2 Followers

Alembic Pharmaceuticals Limited Income Statement

Last quarter (Q2 2026), Alembic Pharmaceuticals Limited's total revenue was ₹19.10B, an increase of 15.91% from the same quarter last year. In Q2, Alembic Pharmaceuticals Limited's net income was ₹1.85B. See Alembic Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 73.45B₹ 66.72B₹ 62.29B₹ 56.53B₹ 53.06B
Gross Profit
₹ 33.10B₹ 47.91B₹ 44.33B₹ 38.78B₹ 38.08B
Operating Expenses
₹ 25.10B₹ 20.90B₹ 19.24B₹ 18.97B₹ 19.77B
Depreciation and Amortization
₹ 3.19B₹ 2.59B₹ 2.53B₹ 2.58B₹ 2.71B
EBITDA
₹ 11.18B₹ 9.89B₹ 9.14B₹ 6.96B₹ 8.59B
Operating Income
₹ 8.00B₹ 27.02B₹ 25.08B₹ 19.81B₹ 18.31B
Other Income/Expenses
₹ -1.06B₹ -19.95B₹ -18.77B₹ -16.26B₹ -12.05B
Pretax Income
₹ 6.94B₹ 7.07B₹ 6.32B₹ 3.55B₹ 6.25B
Net Income
₹ 6.75B₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B
Per Share Metrics
Basic EPS
₹ 34.33₹ 29.68₹ 31.33₹ 17.40₹ 26.50
Diluted EPS
₹ 34.33₹ 29.68₹ 31.33₹ 17.40₹ 26.50
Weighted Average Shares Outstanding
 196.55M 196.56M 196.56M 196.56M 196.56M
Weighted Average Shares Outstanding (Diluted)
 196.55M 196.56M 196.56M 196.56M 196.56M
Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History